Laumas Sandeep

Laumas Sandeep is listed in filings as Director at Unicycive Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 18, 2026, including sale activity. Recent filings connect the profile to Unicycive Therapeutics, Inc. (UNCY), BioXcel Therapeutics, Inc. (BTAI), and Instil Bio, Inc. (TIL). The current snapshot covers public activity from Jun 11, 2024 to May 18, 2026. Reported amounts are shown as $34.2K to $297.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.